Reovirus as a novel oncolytic agent
Open Access
- 15 April 2000
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 105 (8) , 1035-1038
- https://doi.org/10.1172/jci9871
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- The Hallmarks of CancerCell, 2000
- The p21-Ras signal transduction pathway and growth regulation in human high-grade gliomasBrain Research Reviews, 1999
- Reovirus Type 3 Chemoimmunotherapy of Murine Lymphoma is Abrogated by CyclosporineCancer Biotherapy, 1995
- Endogenous inhibitors of the dsRNA-dependent eIF-2α protein kinase PKR in normal and ras-transformed cellsBiochimie, 1994
- Gene amplification and tumor progressionBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1993
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genesPublished by Elsevier ,1988
- Reovirus type 3 infection in patients with primary biliary cirrhosis and primary sclerosing cholangitisJournal of Hepatology, 1987
- The preferential cytotoxicity of reovirus for certain transformed cell linesArchiv für die gesamte Virusforschung, 1977
- ReovirusesScience, 1959